Rekha G. Priyadarshini

Hyderabad, TG, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Current knowledge in pharmacogenomics and precision medicine: perspectives of the PGRN global PGx committee on improving drug therapies in underrepresented ethnic populations.

Current knowledge in pharmacogenomics and precision medicine: perspectives of the PGRN global PGx committee on improving drug therapies in underrepresented ethnic populations.

Journal: Pharmacogenomics

Published: August 11, 2026

Immunohistochemical Evaluation of Phosphatase and Tensin Homolog (PTEN) Expression in Endometrial Lesions: A Cross-Sectional Study in a Tertiary Care Center in South India.

Immunohistochemical Evaluation of Phosphatase and Tensin Homolog (PTEN) Expression in Endometrial Lesions: A Cross-Sectional Study in a Tertiary Care Center in South India.

Journal: Cureus

Published: October 13, 2025

Exploring the Knowledge and Attitudes of Physicians on Polypharmacy and Deprescribing in Clinical Practice: a Cross-Sectional Study.

Exploring the Knowledge and Attitudes of Physicians on Polypharmacy and Deprescribing in Clinical Practice: a Cross-Sectional Study.

Journal: Maedica

Published: April 15, 2025

Managing the monthly: a mixed methods study on menstrual waste management among adolescent girls from South India.

Managing the monthly: a mixed methods study on menstrual waste management among adolescent girls from South India.

Journal: International journal of adolescent medicine and health

Published: March 30, 2025

Towards safer medication use in older adults: Investigating barriers and facilitators of deprescribing.

Towards safer medication use in older adults: Investigating barriers and facilitators of deprescribing.

Journal: British journal of clinical pharmacology

Published: March 29, 2025

PCNA and MCM 2 in Odontogenic Tumors: An Immunnohistological Study.

PCNA and MCM 2 in Odontogenic Tumors: An Immunnohistological Study.

Journal: Journal of pharmacy & bioallied sciences

Published: October 09, 2024

A limited low-cost method to identify subgroup of B cell-Acute Lymphoblastic Lukemia (B-ALL) with overexpressed CRLF2, JAK2, ABL1 - results from a prospective study.

A limited low-cost method to identify subgroup of B cell-Acute Lymphoblastic Lukemia (B-ALL) with overexpressed CRLF2, JAK2, ABL1 - results from a prospective study.

Journal: Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion

Published: August 13, 2024

Assessing the Efficacy of the ARMOR Tool-Based Deprescribing Intervention for Fall Risk Reduction in Older Patients Taking Fall Risk-Increasing Drugs (DeFRID Trial): Protocol for a Randomized Controlled Trial.

Assessing the Efficacy of the ARMOR Tool-Based Deprescribing Intervention for Fall Risk Reduction in Older Patients Taking Fall Risk-Increasing Drugs (DeFRID Trial): Protocol for a Randomized Controlled Trial.

Journal: JMIR research protocols

Published: December 19, 2023

Clinical and immunological responses to COVID-19 vaccination in rheumatoid arthritis patients on disease modifying antirheumatic drugs: a cross-sectional study.

Clinical and immunological responses to COVID-19 vaccination in rheumatoid arthritis patients on disease modifying antirheumatic drugs: a cross-sectional study.

Journal: Journal of rheumatic diseases

Published: August 31, 2023

Efficacy and Safety of Anti-SARS-CoV-2 Monoclonal Antibodies: An Updated Review.

Efficacy and Safety of Anti-SARS-CoV-2 Monoclonal Antibodies: An Updated Review.

Journal: Monoclonal antibodies in immunodiagnosis and immunotherapy

Published: May 02, 2023

Anti-spike Antibody Status in Pre-vaccinated Healthy Participants and Rheumatoid Arthritis Patients During the Third Wave of COVID-19.

Anti-spike Antibody Status in Pre-vaccinated Healthy Participants and Rheumatoid Arthritis Patients During the Third Wave of COVID-19.

Journal: Cureus

Published: April 09, 2023

Utilization of Bioinorganic Nanodrugs and Nanomaterials for the Control of Infectious Diseases Using Deep Learning.

Utilization of Bioinorganic Nanodrugs and Nanomaterials for the Control of Infectious Diseases Using Deep Learning.

Journal: BioMed research international

Published: September 14, 2022

Showing 1-12 of 22

Last Updated: 09/26/2026